India's top drug maker Sun Pharmaceutical Industries has announced today the launch of a generic version of semaglutide, the ...

The company has received approval from the Drugs Controller General of India (DCGI) to manufacture and market Semaglutide ...

Sun Pharma receives DCGI approval to launch generic semaglutide injection, Noveltreat, for weight management in India.

DCGI approval to Sun Pharma comes amid an ongoing patent dispute with Novo Nordisk in the Delhi High Court. The case relates ...

Noveltreat to be available in five dose strengths of 0.25 mg/0.5 mL, 0.5 mg/0.5 mL, 1 mg/0.5 mL, 1.7 mg/0.75 mL and 2.4 mg/0.75 mL, with a maintenance dose of 2.4 mg administered once weekly ...

Sun Pharma receives DCGI approval to launch generic Wegovy semaglutide in India after patent expiry in March 2026. Check ...

Sun Pharma receives DCGI approval to market generic semaglutide injection for chronic weight management in India. Launch after patent expiry.

Sun Pharmaceutical Industries announced that it has received approval from the Drugs Controller General of India (DCGI) to manufacture and market a generic version of semaglutide injection.

Sun ‍Pharmaceutical Industries , India's top ​drugmaker by revenue, said ‌on Friday it has ​received regulatory approval to manufacture and sell the generic version of blockbuster weight-loss drug ...

This creamy one-pan vegan mushroom pasta combines tender tagliatelle with sautéed mushrooms, red onion, garlic, and sun-dried ...

Besides Sun Pharma, a growing roster of Indian drugmakers is lining up cheaper generic versions of semaglutide ahead of the ...

In downtown Manila, rows upon rows of headstones are laid out on the gentle slopes of a hilltop, the largest single burial ground for US World War II casualties.